Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: Instanyl (Fentanyl citrate) — Istituto Gentili S.r.l.
EU authorization for Instanyl (fentanyl citrate) by Istituto Gentili S.r.l. for pain and cancer-related indications.
-
EMA approval · 2026-08-04EMA Authorised: Dzuveo (sufentanil citrate) — Laboratoire Aguettant
The EMA has authorised Dzuveo (sufentanil citrate) from Laboratoire Aguettant for pain management.
-
EMA approval · 2026-07-29EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH
PecFent (fentanyl) by Gruenenthal GmbH has been authorised for use in pain and cancer indications in the EU.
-
EMA approval · 2026-07-15EMA Authorised: PecFent (fentanyl) — Gruenenthal GmbH
EMA authorizes PecFent (fentanyl) by Gruenenthal GmbH for pain and cancer indications.
-
EMA approval · 2026-04-15EMA Authorised: Prialt (ziconotide) — Esteve Pharmaceuticals GmbH
EMA authorised Prialt (ziconotide) for intrathecal use to treat pain, with Esteve Pharmaceuticals GmbH as the marketing authorisation holder…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-02-13FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for tramadol hydrochloride from Unichem Pharmaceuticals (USA), Inc., effectively approving a new or …
-
FDA approval · 2026-01-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride submitted by VistaPharm, LLC.
-
FDA approval · 2026-01-08FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for hydrocodone bitartrate and acetaminophen tablets, adding a generic hydrocod…
-
FDA approval · 2026-01-06FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for oxycodone hydrochloride under the ANDA, authorizing its continued manufactu…
-
FDA approval · 2026-01-02FDA Approved: ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's acetaminophen 250 mg and ibuprofen 125 mg tablets through an original application (ANDA 219053).
-
FDA approval · 2025-12-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for the hydrocodone bitartrate and acetaminophen combination product from Upsher-Smith Laboratories,…
-
FDA approval · 2025-12-29FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)
The FDA approved Eywa Pharma Inc's supplemental application for the generic oxycodone/acetaminophen product, updating its labeling for this …
-
FDA approval · 2025-12-23FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for tramadol hydrochloride submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2025-12-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for methadone hydrochloride from VistaPharm, LLC.
-
FDA approval · 2025-12-23FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for oxycodone hydrochloride from ANI Pharmaceuticals, indicating a new or updated ANDA product u…
-
FDA approval · 2025-12-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC, enabling the marketing of the generic product in the…
-
FDA approval · 2025-12-23FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for tramadol hydrochloride from Advagen Pharma Limited under ANDA 208708, indicating an additional a…
-
FDA approval · 2025-12-23FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental ANDA for oxymorphone hydrochloride from Epic Pharma, LLC, authorizing a generic oxymorphone hydrochloride produc…
-
FDA approval · 2025-12-23FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Strides Pharma Science Limited, expa…
-
FDA approval · 2025-12-22FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for a generic oxycodone and acetaminophen product from KVK-Tech, Inc.
-
FDA approval · 2025-12-22FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for Hydrocodone Bitartrate and Acetaminophen, approving a generic analges…
-
FDA approval · 2025-12-22FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for BUTRANS (buprenorphine) from Purdue Pharma LP.
-
FDA approval · 2025-12-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for methadone hydrochloride in a generic product by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2025-12-22FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P., resulting in an updat…
-
FDA approval · 2025-12-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Aurolife Pharma’s methadone hydrochloride product, enabling its marketing as a generic methadone…